Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.

Chesney MA, Chambers DB, Kahn JO.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):266-71.

PMID:
9402073
2.

Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.

Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL.

J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):234-8.

PMID:
16951646
3.

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, Willoughby B, Remis R.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):521-8.

PMID:
12473841
4.

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.

Jackson DJ, Martin HL Jr, Bwayo JJ, Nyange PM, Rakwar JP, Kashonga F, Mandaliya K, Ndinya-Achola JO, Kreiss JK.

AIDS. 1995 Nov;9(11):1279-83.

PMID:
8561982
5.

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Lampinen TM, Chan K, Remis RS, Merid MF, Rusch M, Vincelette J, Logue K, Popovic V, Alary M, Schechter MT, Hogg RS.

CMAJ. 2005 Feb 15;172(4):479-83.

6.

Changing sexual behavior among gay male repeat testers for HIV: a randomized, controlled trial of a single-session intervention.

Dilley JW, Woods WJ, Sabatino J, Lihatsh T, Adler B, Casey S, Rinaldi J, Brand R, McFarland W.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):177-86.

PMID:
12045680
7.

Motivations for participating in an HIV vaccine efficacy trial.

Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):359-64.

PMID:
15980699
8.

Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.

Jenkins RA, Chinaworapong S, Morgan PA, Ruangyuttikarn C, Sontirat A, Chiu J, Michael RA, Nitayaphan S, Khamboonruang C.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):171-7.

PMID:
9637582
9.

HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD; VISION/VAX004 Study Team.

J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101.

PMID:
15851919
10.

Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men.

McKirnan DJ, Doetsch J, Vanable P, Buchbinder S, Douglas JM, Judson F.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S285-8.

PMID:
7865320
11.

Human immunodeficiency virus incidence and risk behavior in the 'Projeto Rio': results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98.

Sutmöller F, Penna TL, de Souza CT, Lambert J; Oswaldo Cruz Foundation STD/HIV Prevention Group.

Int J Infect Dis. 2002 Dec;6(4):259-65.

PMID:
12718818
12.

Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.

Van de Ven P, Mao L, Crawford J, Prestage G, Grulich A, Kaldor J, Kippax S.

Int J STD AIDS. 2005 Apr;16(4):314-7.

PMID:
15899086
13.

Will preventive HIV vaccine efficacy trials be possible with female injection drug users?

Meyers K, Metzger DS, McLellan AT, Navaline H, Sheon AR, Woody GE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):577-85.

PMID:
8548338
14.

Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.

Hays RB, Kegeles SM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):164-71.

PMID:
10048904
15.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand.

van Griensvan F, Keawkungwal J, Tappero JW, Sangkum U, Pitisuttithum P, Vanichseni S, Suntharasamai P, Orelind K, Gee C, Choopanya K; Bangkok Vaccine Evaluation Group.

AIDS. 2004 Jan 23;18(2):295-301.

PMID:
15075548
16.

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Markowitz LE, Sirisopana N, Charonwatanachokchai A, Julvanichpong W, Siraprapasiri T, Palanuvej T, Siriwongrangsun P, Tungsakul V, Pumratana K, Chitwarakorn A, Michael RA, Brown AE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):488-94.

PMID:
10225232
17.

Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials.

Scheer S, Douglas JM Jr, Vittinghoff E, Bartholow BN, McKirnan D, Judson FN, MacQueen KM, Buchbinder S.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):172-8.

PMID:
10048905
18.

Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors.

Dilley JW, Woods WJ, Loeb L, Nelson K, Sheon N, Mullan J, Adler B, Chen S, McFarland W.

J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):569-77.

PMID:
17310937
19.

Risk factors for HIV infection among men who have sex with men.

Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, Barresi PJ, Coates TJ, Chesney MA, Buchbinder S.

AIDS. 2006 Mar 21;20(5):731-9.

PMID:
16514304
20.

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand.

Jenkins RA, Thapinta D, Morgan PA, Wongkamhaeng S, Sornsathapornkul P, Bussaratid V, Sontirat A, Pitisuttithum P, Thongchareoen P, Khamboonruang C, Suriyanon V, Nitayaphan S, Brown AE; Thai AIDS Vaccine Evaluation Group.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):592-9.

PMID:
16284537

Supplemental Content

Support Center